Atropine Sulfate Injection
Product Images NDC 51662-1311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 51662-1311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Serialized Pouch Label (51662131121 Atropine Pouch Label)

Serialized Pouch Label (51662131121 Atropine Pouch Label)
Atropine Sulfate Injection, USP is a medication provided in a 20mL vial, containing 8mg/20mL (0.4mg/mL) of the active ingredient. The medication is intended for intramuscular, intravenous, or subcutaneous use, and the usual dosage can be found in the package insert. The medication is supposed to be stored in a controlled room temperature range of 20-25°C (68-77°F). This medication is authorized for prescription use only and has an NDC number of 51662-13511-2. The medication is manufactured by HF Acquisition Co., LLC, located in Mukilteo, WA 98275.*
FDA Label Image

Case (51662131138 Atropine Case Label)

Case (51662131138 Atropine Case Label)
ATROPINE SULFATE INJECTION is an 8mg/20mL (0.4mg/mL) drug that comes in a 20mL vial, and is boxed in 25s. The package insert contains more information about dosage and administration. The drug should be stored at a controlled room temperature between 20-25°C (68-77°F). The product is manufactured by HF Acquisition Co., LLC in Mukilteo, Washington. The NDC for both the product and manufacturer is available, and the product is available only by prescription. Lot 12345 with an expiration date of 2030-06-30.*
FDA Label Image

Serialized Rfid (51662131138 Atropine Rfid Label)

Serialized Rfid (51662131138 Atropine Rfid Label)
FDA Label Image

Adverse Event Tabel (Adverse Event)

Adverse Event Tabel (Adverse Event)
This text appears to describe the range of effects that can occur when taking doses of a medication in milligrams, starting from 0.5mg and increasing up to a potentially fatal dose of 65mg. The text notes that at lower doses, one may experience slight dryness of the nose and mouth, as well as bradycardia (slowing of the heart). However, at higher doses, symptoms can escalate to include dry mouth, tachycardia (acceleration of the heart), mydriasis (dilation of the pupils), blurring of vision, difficulty speaking or swallowing, headache, and restlessness, among others. At extremely high doses, the medication can cause ataxia (loss of muscle control), excitement, disorientation, hallucinations, delirium, and even coma.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
This appears to be a chart showing the quantity of Atropine Sulfate Solution (in milliliters) required based on the desired dosage in milligrams per milliliter. It provides various dosage options ranging from 0.1mg/mL to 1mg/mL.*
FDA Label Image
Logo (Logo)
FDA Label Image

Serialized Vial (Serialized 51662 1311 1 Atropine 20ml Vial)

Serialized Vial (Serialized 51662 1311 1 Atropine 20ml Vial)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Vial (Vial Label)

Vial (Vial Label)
This seems to be a label of a medication called "Atropine Sulfate Injection" with a concentration of 8mg/20mL. It is available in a multiple dose vial for IM, IV or SC use. No further information is provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.